Neuralink Expands Brain Implant Trials with 12 Global Patients 
Jared Isaacman Confirmed as NASA Administrator, Becomes 15th Leader of U.S. Space Agency 
Silver Prices Hit Record Highs: How Silver Is Traded and Why Demand Is Surging 
CDC Vaccine Review Sparks Controversy Over Thimerosal Study Citation 
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets 
Eli Lilly Becomes First Pharma Giant to Hit $1 Trillion Amid Soaring Weight-Loss Drug Demand 
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio 
NASA Astronauts Wilmore and Williams Recover After Boeing Starliner Delay 
U.S. Dollar Steadies Ahead of Fed Minutes as Markets Eye Policy Divisions 
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths 
Oil Prices Slip Slightly as Markets Weigh Geopolitical Risks and Supply Glut Concerns 
Oil Prices Slide in 2025 as Oversupply and Geopolitical Risks Shape Market Outlook 
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change 
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions 
A new diagnostic method that ascertains if a person is suffering from Parkinson’s disease or dementia by looking at the manner of walking has been patented.
A new diagnostic technique developed by a St. Mary's Hospital research team in Uijeongbu has been patented and put up for patent registration, which analyses data from an individual's shoes to detect neurological disorders.
Most degenerative brain disorders, such as Parkinson's disease, dementia, and Lou Gehrig's disease, occur at an older age.
Currently, a costly MRI or a PET scan is required for such diagnosis, as well as frequent visits to the hospital.
The new approach, on the other hand, employs a "smart insole" that is placed inside a shoe and collects data from its sensors, which is then analyzed to assess the brain health of the wearer.
The new technique achieved an accuracy of 98.1 percent for the diagnosis of Parkinson's disease, as well as 83.2 percent for differentiating whether an illness is vascular or degenerative.
